HB273 Alabama 2012 Session

Summary

Primary Sponsor

Jim McClendon

Republican

Session

Regular Session 2012

Title

Medicaid programs, ensuring appropriate access to medicines for premature infants, created, Medicaid program required to develop and implement policies to streamline process for access to covered drug for premature infants.

Summary

HB273 would require Alabama’s Medicaid Agency to create policies to speed up and simplify access to covered medicines for premature infants.

What This Bill Does

The bill requires the Medicaid Agency to develop and implement policies to streamline prior authorization for outpatient drugs used by premature infants and to ensure timely access. It sets a 24-hour target to review and decide on prior authorization requests, allows electronic, fax, or phone submissions, and deems requests approved if not decided in time. It mandates transparency by posting PA requirements/forms/rationale/appeals information, creates a strong appeals process (including continued coverage during appeals), and requires dosing to match FDA-prescribing information. It also requires monitoring of health outcomes and annual reporting to the Legislature, and to develop common standards across programs; the rules apply to all Medicaid programs in the state.

Who It Affects

• Premature infants enrolled in Alabama Medicaid and their families, who would gain faster and clearer access to needed outpatient drugs.
• Physicians, caregivers, and other healthcare providers (and Medicaid staff) who use the PA process and manage care for premature infants, who must follow the new streamlined procedures and reporting requirements.

Key Provisions

• Create the Ensuring Appropriate Access to Medicines for Premature Infants Act and require streamlined prior authorization (PA) for covered outpatient drugs for premature infants.
• By July 1, 2012, implement policies to ensure fast-track 24-hour PA decisions; respond with approval/denial and rationale; automatic deeming as approved if not decided within 24 hours; allow electronic, fax, or phone PA submissions; notify via time-stamped notices.
• Post all PA requirements, forms, rationale, and appeals processes on the Medicaid Agency website by drug/therapeutic area for transparency.
• Establish an appeals process with continued coverage during appeals, ability to review records, timely decisions, and consumer protections per national standards.
• Ensure medicines for premature infants are dosed and used according to FDA-prescribing information.
• Monitor health outcomes (readmissions, ER visits, outpatient visits) for denied drugs; collect data annually and report findings to the Legislature.
• Develop standards and common practices for all Medicaid programs to ensure timely access; make these provisions binding for all programs serving Medicaid patients in Alabama.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Medicaid Agency